BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36675102)

  • 41. Structural, enzymatic and pharmacological profiles of AplTX-II - A basic sPLA
    Resende LM; Almeida JR; Guaraca-Medina TA; Viegas MF; Soares AM; Ramos MJ; Fernandes PA; Marangoni S; Da Silva SL
    Int J Biol Macromol; 2021 Apr; 175():572-585. PubMed ID: 33529631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor.
    Rouault M; Le Calvez C; Boilard E; Surrel F; Singer A; Ghomashchi F; Bezzine S; Scarzello S; Bollinger J; Gelb MH; Lambeau G
    Biochemistry; 2007 Feb; 46(6):1647-62. PubMed ID: 17279628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular weight variations in the diversity of phospholipase A2 forms in reptile venoms.
    DuBourdieu DJ; Kawaguchi H; Shier WT
    Toxicon; 1987; 25(3):333-43. PubMed ID: 3590214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current Knowledge on Snake Dry Bites.
    Pucca MB; Knudsen C; S Oliveira I; Rimbault C; A Cerni F; Wen FH; Sachett J; Sartim MA; Laustsen AH; Monteiro WM
    Toxins (Basel); 2020 Oct; 12(11):. PubMed ID: 33105644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Secretory phospholipase A2.
    Murakami M; Kudo I
    Biol Pharm Bull; 2004 Aug; 27(8):1158-64. PubMed ID: 15305013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An overview of the immune modulating effects of enzymatic toxins from snake venoms.
    Burin SM; Menaldo DL; Sampaio SV; Frantz FG; Castro FA
    Int J Biol Macromol; 2018 Apr; 109():664-671. PubMed ID: 29274419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Secreted Phospholipases A2 - not just Enzymes.
    Sribar J; Križaj I
    Acta Chim Slov; 2011 Dec; 58(4):678-88. PubMed ID: 24061115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemical modifications of phospholipases A2 from snake venoms: effects on catalytic and pharmacological properties.
    Soares AM; Giglio JR
    Toxicon; 2003 Dec; 42(8):855-68. PubMed ID: 15019487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kinetic evaluation of cell membrane hydrolysis during apoptosis by human isoforms of secretory phospholipase A2.
    Olson ED; Nelson J; Griffith K; Nguyen T; Streeter M; Wilson-Ashworth HA; Gelb MH; Judd AM; Bell JD
    J Biol Chem; 2010 Apr; 285(14):10993-1002. PubMed ID: 20139082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Secreted Phospholipase A
    Yamamoto K; Miki Y; Sato H; Murase R; Taketomi Y; Murakami M
    Methods Enzymol; 2017; 583():101-117. PubMed ID: 28063487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The human 180-kDa receptor for secretory phospholipases A2. Molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization.
    Ancian P; Lambeau G; Mattéi MG; Lazdunski M
    J Biol Chem; 1995 Apr; 270(15):8963-70. PubMed ID: 7721806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Varespladib (LY315920) and Methyl Varespladib (LY333013) Abrogate or Delay Lethality Induced by Presynaptically Acting Neurotoxic Snake Venoms.
    Gutiérrez JM; Lewin MR; Williams DJ; Lomonte B
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32093386
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Secretory Phospholipase A2s in Insulin Resistance and Metabolism.
    Kuefner MS
    Front Endocrinol (Lausanne); 2021; 12():732726. PubMed ID: 34512555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Edema, hyperalgesia and myonecrosis induced by Brazilian bothropic venoms: overview of the last decade.
    Mamede CCN; de Sousa Simamoto BB; da Cunha Pereira DF; de Oliveira Costa J; Ribeiro MSM; de Oliveira F
    Toxicon; 2020 Nov; 187():10-18. PubMed ID: 32846146
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Snake venom phospholipases A2. A fluorescence study of their binding to phospholipid vesicles correlation with their anticoagulant activities.
    Prigent-Dachary J; Boffa MC; Boisseau MR; Dufourcq J
    J Biol Chem; 1980 Aug; 255(16):7734-9. PubMed ID: 7400142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natural phospholipase A(2) myotoxin inhibitor proteins from snakes, mammals and plants.
    Lizano S; Domont G; Perales J
    Toxicon; 2003 Dec; 42(8):963-77. PubMed ID: 15019494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comprehensive Study of the Proteome and Transcriptome of the Venom of the Most Venomous European Viper: Discovery of a New Subclass of Ancestral Snake Venom Metalloproteinase Precursor-Derived Proteins.
    Leonardi A; Sajevic T; Pungerčar J; Križaj I
    J Proteome Res; 2019 May; 18(5):2287-2309. PubMed ID: 31017792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Receptors for a growing family of secreted phospholipases A2.
    Lambeau G; Lazdunski M
    Trends Pharmacol Sci; 1999 Apr; 20(4):162-70. PubMed ID: 10322502
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Secretory phospholipases A2 induce beta-glucuronidase release and IL-6 production from human lung macrophages.
    Triggiani M; Granata F; Oriente A; De Marino V; Gentile M; Calabrese C; Palumbo C; Marone G
    J Immunol; 2000 May; 164(9):4908-15. PubMed ID: 10779801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Snake venom phospholipase A2 inhibitors: medicinal chemistry and therapeutic potential.
    Marcussi S; Sant'Ana CD; Oliveira CZ; Rueda AQ; Menaldo DL; Beleboni RO; Stabeli RG; Giglio JR; Fontes MR; Soares AM
    Curr Top Med Chem; 2007; 7(8):743-56. PubMed ID: 17456038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.